FDA Import Refusal 799-9097640-9/11/1 — ASTRAZENECA PHARMA
The FDA refused shipment 799-9097640-9/11/1 from ASTRAZENECA PHARMA (India) on January 26, 2024. The refused product falls under Drugs and Biologics — DAPAGLIFLOZIN (ANTI-DIABETIC). Cited charge: 75 This firm has 4 other import refusals on record.
Refusal Details
- Date
- January 26, 2024
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61PDB70 DAPAGLIFLOZIN (ANTI-DIABETIC)
- Charges
- 75